Idiopathic inflammatory myopathy associated with Sjögren’s disease: features of a distinct clinical entity
The study suggests that IIM-SjD is characterized by more asymmetric muscle weakness and extramuscular involvement. Enhanced immunosuppression led to better outcomes in patients with poly- or dermatomyositis, while IBM was linked to higher disease activity. Further research is needed to clarify underlying mechanisms.
Authors
- Thomas Skripuletz (ORCID: https://orcid.org/0000-0001-8550-335X)
- Tabea Seeliger (ORCID: https://orcid.org/0000-0002-6018-6826)
- Sandra Nay (ORCID: https://orcid.org/0000-0002-4986-1181)
- Torsten Witte (ORCID: https://orcid.org/0000-0003-4531-0267)
- Philipp Schwenkenbecher (ORCID: https://orcid.org/0000-0002-1260-1650)
- Franz Felix Konen (ORCID: https://orcid.org/0000-0002-8609-5674)
- Lea Grote‐Levi
- Konstantin Fritz Jendretzky
- Yunus Emre Güzeloglu
- Diana Ernst (ORCID: https://orcid.org/0000-0003-0736-6243)
- Christine Gründges
Institutions
- Medizinische Hochschule Hannover (DE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.3389/fimmu.2025.1654576
- Citations
- 2
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Bristol-Myers Squibb
- Biogen
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- CSL Behring
- Argenx
- Deutsche Forschungsgemeinschaft
- Medizinischen Hochschule Hannover
- Chugai Pharmaceutical